NutriBand Inc. NTRB
Nasdaq · stock · Orthopedic, Prosthetic & Surgical Appliances & Supplies · website · IPO 2017-06-20 · LEI
NutriBand Inc. financials (annual)
Bars are annual figures from 2017 to 2026; red bars are negative (a loss or cash outflow).
| Metric | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.0M | $2.1M | $2.1M | $2.1M | $1.4M | $943,702 | $119,364 | $245,285 | — | — |
| Gross profit | $566,308 | $743,317 | $862,105 | $750,404 | $554,310 | $316,234 | — | — | — | — |
| R&D expense | $1.9M | $3.1M | $2.0M | $982,227 | $411,383 | — | — | — | — | — |
| SG&A expense | $7.0M | $4.3M | $3.8M | $3.9M | $4.0M | $2.9M | $1.8M | $3.3M | $171,946 | $151,260 |
| Operating income | -$8.3M | -$10.3M | -$4.9M | -$4.5M | -$6.1M | -$2.6M | -$2.0M | -$3.3M | -$2.7M | -$151,260 |
| Interest expense | — | — | $75,815 | $8,289 | $118,421 | $280,686 | $73,413 | — | — | — |
| Net income | -$8.2M | -$10.5M | -$5.5M | -$4.5M | -$6.2M | -$2.9M | -$2.7M | -$3.3M | -$2.7M | -$151,260 |
| EPS (diluted) | $-2.58 | $-0.99 | $-0.69 | $-0.53 | $-0.80 | — | — | — | — | — |
| Operating cash flow | -$5.1M | -$4.6M | -$3.5M | -$3.0M | -$2.8M | -$297,055 | -$894,470 | -$1.1M | -$92,858 | -$147,923 |
| Free cash flow | -$5.1M | -$4.7M | -$3.6M | -$3.1M | -$2.9M | — | — | -$1.1M | — | — |
| Cash & equivalents | $4.6M | $4.3M | $492,942 | $2.0M | $4.9M | $151,993 | $10,181 | $474,653 | — | $27,124 |
| Inventory | $117,987 | $212,041 | $168,605 | $229,335 | $131,648 | $52,848 | — | — | $4,133 | $8,048 |
| Total assets | $7.5M | $7.5M | $7.5M | $9.5M | $12.7M | $9.9M | $2.2M | $2.8M | $164,899 | $37,727 |
| Total liabilities | $868,447 | $1.0M | $1.1M | $883,387 | $880,375 | $2.8M | $2.0M | — | — | $14,618 |
| Shareholders' equity | $6.7M | $6.4M | $6.4M | $8.6M | $11.9M | $7.1M | $175,433 | $2.4M | $121,508 | $23,109 |
Growth · year-over-year · Revenue CAGR 35.3%
| Metric | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | -4.8% | +2.6% | +0.3% | +46.2% | +50.7% | +690.6% | -51.3% | — | — | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2026-01-31. Facts plus Stocktoria's own computed scores — not investment advice.